MPWT
GYRE icon

MassMutual Private Wealth & Trust’s Gyre Therapeutics GYRE Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12
Closed -$82 – 2440
2026
Q1 		$84 Buy
+12
New +$93 ﹤0.01% 2361

Other funds holding GYRE

SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

MassMutual Private Wealth & Trust's GYRE Position: Q2 2026 in Review

MassMutual Private Wealth & Trust sold out of Gyre Therapeutics (GYRE) in Q2 2026, closing a stake of 12 shares — an estimated $82 sold.

MassMutual Private Wealth & Trust first reported a position in GYRE in Q1 2026 and held it in 1 quarter. The position peaked at $84 in Q1 2026. 14 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • MassMutual Private Wealth & Trust reported no remaining Gyre Therapeutics position as of Q2 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 12 Gyre Therapeutics shares in Q2 2026, an estimated $82.
  • MassMutual Private Wealth & Trust first reported a position in Gyre Therapeutics in Q1 2026 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Gyre Therapeutics position peaked at $84 in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.